Dysfunctional uterine bleeding.
The etiology and pathogenesis of dysfunctional uterine bleeding are discussed. For both age groups, adolescents and perimenopausal women, gonadotropin-steroid patterns as well as endometrial changes are presented. Methods of evaluation and therapy are described, including curettage and judicious of estrogen-progestogen combinations. Finally, long-term follow-ups of these patients are presented, with plans for reevaluation as well as palliative treatment based on the bleeding patterns and gonadotropin levels.
D000293:Adolescent; D003280:Contraceptives, Oral, Synthetic / Q000627:therapeutic use; D004967:Estrogens / Q000096:biosynthesis / Q000378:metabolism; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008525:Medroxyprogesterone / Q000627:therapeutic use; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery
D003280:Contraceptives, Oral, Synthetic; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D004997:Ethinyl Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008525:Medroxyprogesterone